[go: up one dir, main page]

TW200614989A - Inhibitors of HCV replication - Google Patents

Inhibitors of HCV replication

Info

Publication number
TW200614989A
TW200614989A TW094126971A TW94126971A TW200614989A TW 200614989 A TW200614989 A TW 200614989A TW 094126971 A TW094126971 A TW 094126971A TW 94126971 A TW94126971 A TW 94126971A TW 200614989 A TW200614989 A TW 200614989A
Authority
TW
Taiwan
Prior art keywords
compounds
inhibitors
hcv replication
hcv
virus
Prior art date
Application number
TW094126971A
Other languages
Chinese (zh)
Inventor
Thomas W Hudyma
xiao-fan Zheng
Feng He
Min Ding
Carl P Bergstrom
Piyasena Hewawasam
Scott W Martin
Robert G Gentles
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of TW200614989A publication Critical patent/TW200614989A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Indole compounds of Formula I are described. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV. Different forms and compositions comprising the compounds are also described as well as methods of preparing the compounds.
TW094126971A 2004-08-09 2005-08-09 Inhibitors of HCV replication TW200614989A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60893204P 2004-08-09 2004-08-09
US66055505P 2005-03-11 2005-03-11

Publications (1)

Publication Number Publication Date
TW200614989A true TW200614989A (en) 2006-05-16

Family

ID=38000777

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094126971A TW200614989A (en) 2004-08-09 2005-08-09 Inhibitors of HCV replication

Country Status (4)

Country Link
AR (1) AR052976A1 (en)
PE (1) PE20060714A1 (en)
RU (1) RU2387655C2 (en)
TW (1) TW200614989A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2466132C1 (en) * 2011-03-09 2012-11-10 Автономная некоммерческая организация "Научно-исследовательский центр биотехнологии антибиотиков и других биологических активных веществ "БИОАН" PIM1-KINASE INHIBITOR 6-[(4-METHYL-I-1-PIPERAZINYL)METHYL]-INDOLO[1',7':1,2,3]PYRROLO[3',4':6,7]AZEPINO[4,5-b]INDOLE-1,3(2H, 10H)-DIONE, METHOD FOR PREPARING AND USING IT

Also Published As

Publication number Publication date
PE20060714A1 (en) 2006-07-09
RU2387655C2 (en) 2010-04-27
AR052976A1 (en) 2007-04-18
RU2007108674A (en) 2008-09-20

Similar Documents

Publication Publication Date Title
TW200745120A (en) Indolobenzazepine HCV NS5B inhibitors
BRPI0514176A (en) hcv replication inhibitors
PL1987038T3 (en) Hcv ns5b inhibitors
TW200745035A (en) Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
ATE469155T1 (en) CYCLOPROPYL-FUSIONED INDOLEBENZAZEPINE HCV NS5B INHIBITORS
NO20090453L (en) Hepatitis C Virus Inhibitors
WO2007140200A3 (en) Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
IL195025A (en) Cyclopropyl fused indolobenzazepine derivatives and pharmaceutical compositions comprising the same as anti-hcv medicament
MX2009009473A (en) Compounds for the treatment of hepatitis c.
ATE542826T1 (en) HEPATITIS C VIRUS INHIBITORS
ATE474827T1 (en) HCV REPLICATION INHIBITORS
MX2009004888A (en) Hepatitis c virus inhibitors.
MX2009004943A (en) Hepatitis c virus inhibitors.
DK2209789T3 (en) Cyclopropyl-condensed indolobenzazepine HCV NS5B inhibitors
DK2250163T3 (en) Hepatitis C virus inhibitors
MX2012004032A (en) Compounds for the treatment of hepatitis c.
ATE522532T1 (en) COMPOUNDS FOR TREATING HEPATITIS C
MX2010001416A (en) Compounds for the treatment of hepatitis c.
ATE494291T1 (en) COMPOUNDS FOR TREATING HEPATITIS C
ATE551343T1 (en) TETRACYCLIC COMPOUNDS FOR THE TREATMENT OF HEPATITIS C
ATE505473T1 (en) CYCLOPROPYL-CONDENSED INDOLOBENZAZEPINE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C
MX2010010061A (en) Compounds for the treatment of hepatitis c.
MX2010010235A (en) Pyrrolidine fused indolobenzadiazepine hcv ns5b inhibitors.
TW200614989A (en) Inhibitors of HCV replication
ATE531373T1 (en) AROMATIC HETEROCYCLIC CONDENSED INDOLOBENZADIAZEPINE HCV NS5B INHIBITORS